Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies

Eduardo C Nascimento-Carvalho1,2, Ângela G Vasconcellos3, Jorge Clarêncio2

  • 1Bahiana School of Medicine and Public Health, Bahiana Foundation for Science Development, Salvador, Brazil.

Pediatric Pulmonology
|September 26, 2019
PubMed

Insights

Interleukin-6 (IL-6) serum levels significantly increased during the acute phase of community-acquired pneumonia (CAP) in children, suggesting IL-6 is a potential biomarker for pneumococcal infections in pediatric CAP cases.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Respiratory medicine

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of hospitalization in children under five.
  • Identifying the etiological agent of CAP is crucial for appropriate treatment and management.
  • Cytokine and chemokine profiles offer insights into the host's immune response during infection.

Purpose of the Study:

  • To compare systemic cytokine and chemokine levels over time in children hospitalized with CAP, differentiating between those with and without pneumococcal infection.
  • To identify potential biomarkers for pneumococcal pneumonia in pediatric CAP.

Main Methods:

  • A prospective study of children under five hospitalized with CAP in Salvador, Brazil.
  • Collection of clinical data and serum samples for etiological investigation and cytokine/chemokine level analysis at admission and follow-up.
  • Analysis of 20 etiological agents and measurement of serum cytokines/chemokines, including interleukin-6 (IL-6).

Main Results:

  • Of 129 children with established etiology, 31 (24.0%) had pneumococcal infection.
  • Convalescent serum samples showed significantly higher levels of IL-6, IL-10, and CCL2, and lower levels of CXCL10 compared to acute samples.
  • While IL-10, CCL2, and CXCL10 levels did not differ between groups, IL-6 levels decreased in patients with pneumococcal infection and increased in those without.

Conclusions:

  • A marked increase in serum IL-6 levels during the acute phase of CAP in children suggests its potential as a biomarker for pneumococcal infection.
  • Further research is warranted to validate IL-6 as a reliable diagnostic marker for pneumococcal CAP in children.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
749
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
792